Previous 10 | Next 10 |
2023-08-08 15:40:25 ET ADC Therapeutics SA (ADCT) Q2 2023 Earnings Conference Call August 08, 2023, 08:30 AM ET Company Participants Eugenia Litz - Vice President of Investor Relations and Corporate Communications Ameet Mallik - Chief Executive Officer Kristen He...
2023-08-08 07:28:32 ET ADC Therapeutics press release ( NYSE: ADCT ): Q2 GAAP EPS of -$0.58 misses by $0.01 . Revenue of $19.2M (+11.0% Y/Y) misses by $22.37M . For further details see: ADC Therapeutics GAAP EPS of -$0.58 misses by $0.01, revenue of $19.2...
2Q 2023 ZYNLONTA ® 1 net sales increased 11% year-over-year; Implemented new go-to-market strategy during the quarter to support growth Operating expenses decreased 20% 2 year-over-year due to portfolio prioritization and organizational efficienc...
LAUSANNE, Switzerland, Aug. 01, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it will host a conference call and live webcast on Tuesday, August 8, 2023 at 8:30 a.m. EDT to report financial results for the second quarter 2023 and provide business updates. To a...
BOSTON and SHANGHAI, China and LAUSANNE, Switzerland, July 24, 2023 (GLOBE NEWSWIRE) -- Overland ADCT BioPharma, a joint venture of Overland Pharmaceuticals (CY) Inc. and ADC Therapeutics SA (NYSE: ADCT), today announced that the China National Medical Products Administration (NMPA) has accepted ...
2023-07-20 17:33:15 ET ADC Therapeutics ( NYSE: ADCT ) stock rose 6% in after-hours trading following news that it was discontinuing a Phase 2 study for its drug Zynlonta in the treatment of lymphoma over safety concerns. The biotech company temporarily halted the study, called ...
LAUSANNE, Switzerland, July 20, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it plans to discontinue the Phase 2 LOTIS-9 clinical trial evaluating ZYNLONTA ® (loncastuximab tesirine-lpyl) and rituximab (Lonca-R) in unfit or frail patients with previously...
2023-07-11 13:19:00 ET Gainers: Eloxx Pharmaceuticals ( ELOX ) +112% . CytoMed Therapeutics Limited ( GDTC ) +102% . Biodexa Pharmaceuticals ( BDRX ) +92% . SOS Limited ( SOS ) +39% . Freeline Therapeutics Holdings ( FRLN ) +33% ...
2023-07-11 10:06:43 ET Gainers: CytoMed Therapeutics ( GDTC ) +128% . Eloxx Pharmaceuticals ( ELOX ) +29% . UpHealth ( UPH ) +13% . Virios Therapeutics ( VIRI ) +13% . Acumen Pharmaceuticals ( ABOS ) +9% . Losers: Jou...
2023-07-11 08:20:47 ET Viridian Therapeutics VRDN -19% following thyroid eye disease asset data . ADC Therapeutics ( ADCT ) -16% announces voluntary pause of enrollment in the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA and Rituximab in unfit or frail previously untre...
News, Short Squeeze, Breakout and More Instantly...
£90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital, Cancer Research Horizons and Lilly participated alongside founding investors Brandon Capital and Sofinnova Partners Funds will be used to ...
LAUSANNE, Switzerland, June 27, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company is set to join the Russell 2000 ® Index and the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, ef...